Back to Results
First PageMeta Content
Stem cells / Carotenoids / Food colorings / Ophthalmology / Macular degeneration / Ranibizumab / Bevacizumab / Vascular endothelial growth factor / Age-Related Eye Disease Study / Biology / Medicine / Vision


AGE-RELATED MACULAR DEGENERATION RESEARCH ADVANCES The results of AREDS2 showed that DHA and EPA did not confer additional benefit in reducing AMD risk. The researchers from AREDS2
Add to Reading List

Document Date: 2014-09-23 13:29:21

Open Document

File Size: 86,03 KB

Share Result on Facebook

Company

StemCells Inc. / Oxford BioMedica / AMD / VisionCare Ophthalmic Technologies / Genentech / Acucela / /

Country

United States / United Kingdom / /

Event

FDA Phase / /

Facility

National Eye Institute / Wilmer Eye Institute / /

IndustryTerm

sustained delivery device / biopharmaceutical / toxic by-products / /

MedicalCondition

disease / macular degeneration / lung cancer / inflammatory repsonses / Age-Related Macular Degeneration / SUMMER2014 Age-Related Macular Degeneration / /

MedicalTreatment

gene therapy / stem cell therapy / /

Organization

Wilmer Eye Institute / National Eye Institute / FDA / DHA / Environmental Protection Agency / Retina Foundation of the Southwest in Dallas / /

Product

Fewer Injections / Avastin / Lucentis / ACU-4429 / CLINICAL TRIALS RetinoStat® / EYLEA™ Preserves Vision / /

Technology

gene therapy / cell therapy / stem cells / /

URL

www.areds2.org / www.FightBlindness.org / /

SocialTag